Plasma exchange to remove heparin-induced thrombocytopenia antibodies and the use of heparin during cardiopulmonary bypass in critically ill cardiac patients

J Heart Lung Transplant. 2018 Aug;37(8):1038-1040. doi: 10.1016/j.healun.2018.04.016. Epub 2018 Apr 27.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies / blood*
  • Antibodies / isolation & purification
  • Cardiopulmonary Bypass*
  • Critical Illness*
  • Female
  • Heart Diseases / surgery
  • Heart-Assist Devices
  • Heparin / adverse effects*
  • Heparin / therapeutic use
  • Humans
  • Male
  • Plasma Exchange*
  • Platelet Count
  • Platelet Factor 4 / immunology*
  • Shock, Cardiogenic / surgery
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / therapy*

Substances

  • Antibodies
  • Platelet Factor 4
  • Heparin